LTR Pharma (ASX:LTP) Days Payable : 0.00 (As of Jun. 2023)

View and export this data going back to 2023. Start your Free Trial

What is LTR Pharma Days Payable?

LTR Pharma's average Accounts Payable for the six months ended in Jun. 2023 was A$0.24 Mil. LTR Pharma's Cost of Goods Sold for the six months ended in Jun. 2023 was A$0.00 Mil.

The historical rank and industry rank for LTR Pharma's Days Payable or its related term are showing as below:

ASX:LTP's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 148.28
* Ranked among companies with meaningful Days Payable only.

LTR Pharma's Days Payable stayed the same from Jun. 2021 (0.00) to Jun. 2023 (0.00).

LTR Pharma Days Payable Historical Data

The historical data trend for LTR Pharma's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LTR Pharma Days Payable Chart

LTR Pharma Annual Data

Trend

Jun21

Jun22

Jun23

Days Payable

LTR Pharma Semi-Annual Data
	Jun21	Jun22	Jun23
Days Payable	-	-	-

Competitive Comparison of LTR Pharma's Days Payable

For the Biotechnology subindustry, LTR Pharma's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LTR Pharma's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LTR Pharma's Days Payable distribution charts can be found below:

* The bar in red indicates where LTR Pharma's Days Payable falls into.

LTR Pharma Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

LTR Pharma's Days Payable for the fiscal year that ended in Jun. 2023 is calculated as

	Days Payable (A: Jun. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Jun. 2022 )	+	Accounts Payable (A: Jun. 2023 ))	/	count )	/	Cost of Goods Sold (A: Jun. 2023 )	*	Days in Period
=	( (0.466	+	0.011)	/	2 )	/	0	*	365
=	0.2385					/	0	*	365
=	N/A

LTR Pharma's Days Payable for the quarter that ended in Jun. 2023 is calculated as:

	Days Payable (Q: Jun. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2022 )	+	Accounts Payable (Q: Jun. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2023 )	*	Days in Period
=	( (0.466	+	0.011)	/	2 )	/	0	*	365 / 2
=	0.2385					/	0	*	365 / 2
=	N/A

LTR Pharma Days Payable Related Terms

Thank you for viewing the detailed overview of LTR Pharma's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

LTR Pharma (ASX:LTP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LTR Pharma Ltd (ASX:LTP) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

9A/204 Alice Street, Brisbane, QLD, AUS, 4000

Website

https://www.ltrpharma.com

LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men's health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on market.

LTR Pharma (ASX:LTP) Headlines

No Headlines